TY - JOUR
T1 - Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018))
AU - Baggi, Alice
AU - Quaglino, Pietro
AU - Rubatto, Marco
AU - Depenni, Roberta
AU - Guida, Michele
AU - Ascierto, Paolo Antonio
AU - Trojaniello, Claudia
AU - Queirolo, Paola
AU - Saponara, Maristella
AU - Peris, Ketty
AU - Spagnolo, Francesco
AU - Bianchi, Luca
AU - De Galitiis, Federica
AU - Potenza, Maria Concetta
AU - Proietti, Ilaria
AU - Marconcini, Riccardo
AU - Botticelli, Andrea
AU - Barbieri, Vito
AU - Barbieri, Pietro Vittorio
AU - Licitra, Lisa
AU - Alfieri, Salvatore
AU - Alfieri, Sergio
AU - Ficorella, Corrado
AU - Cortellini, Alessio
AU - Fargnoli, Maria Concetta
AU - Troiani, Teresa
AU - Tondulli, Luca
AU - Zamparini, Manuel
AU - Bossi, Paolo
PY - 2022
Y1 - 2022
N2 - The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for ‘Antibiotic intake (within 1 month before therapy)’ and ‘Haemoglobin’. The correct table in full is given here.
AB - The authors regret that some Author information was incorrectly given in the published article. Author Manuel Zamparini was missed in the Author list, and the listed affiliation for Paola Queirolo was incorrect. The full and correct details for the Authors are: Paola Queirolo Division of Melanoma, Sarcomas and Rare Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy Manuel Zamparini University of Brescia, Department of Medical-Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, ASST-Spedali Civili, Brescia, Lombardia, ItalyThe Authors also note that values in the first column of Table 4 were mistakenly reversed for ‘Antibiotic intake (within 1 month before therapy)’ and ‘Haemoglobin’. The correct table in full is given here.
KW - cemiplimab
KW - cemiplimab
UR - http://hdl.handle.net/10807/206063
U2 - 10.1016/j.ejca.2022.02.027
DO - 10.1016/j.ejca.2022.02.027
M3 - Article
SN - 0959-8049
VL - 166
SP - 309
EP - 310
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -
